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Letters to the Editorincludes imaging data, such as cardio-
vascular magnetic resonance imaging
(MRI) or echocardiography, and com-
plete hemodynamic assessment and
laboratory data. Cardiovascular MRI
generally provides superior RV func-
tional assessment compared with echo-
cardiography. Unfortunately, not all
patients being evaluated for cardiac
surgery are candidates for cardiovascu-
lar MRI because of hemodynamic
instability or the presence of incompat-
ible devices, such as pacemakers or de-
fibrillators, intra-aortic balloon pumps,
and left ventricular assist devices.
Echocardiography, either transthoracic
or transesophageal, can be performed
at the bedside or in the operating
room, and therefore has the advantage
of providing immediate feedback on
the impact of various interventions,
such as fluid administration, adjust-
ment of ventilator parameters, pressor
and inotrope adjustment, and weaning
from cardiopulmonary bypass.
A thorough hemodynamic evalua-
tion is required to interpret the signif-
icance of pulmonary artery pressures.
As RV dysfunction progresses to
outright RV failure, pulmonary pres-
sures and cardiac output decrease,
and right atrial pressure increases.
This concept has been used widely to
predict the risk of RV failure after
left ventricular assist device place-
ment with the RV stroke work index
([pulmonary artery mean – radial ar-
tery mean] $ confidence interval/haz-
ard ratio).1 A simpler determination
of the ratio of right atrial pressure to
pulmonary capillary wedge pressure
is insightful, with values greater than
0.63 indicating higher risk for RV
failure.2
Finally, laboratory evaluation of he-
patic and renal function provides
another means of assessing RV func-
tion. Elevated aspartate aminotrans-
ferase, bilirubin, and blood urea
nitrogen are predictive of RV failure
after left ventricular assist device
placement.2,3 Likewise, the Model
for End-Stage Liver Disease, consist-
ing of total bilirubin, internationalThe Journalnormalized ratio, and creatinine, pre-
dicts mortality for tricuspid valve
surgery.4
The final major point of our publica-
tion is that pulmonary hypertension
in the setting of isolated coronary ar-
tery bypass grafting carries a higher
risk compared with valvular heart dis-
ease, likely because pulmonary pres-
sures rapidly improve with correction
of valve lesions but not with revas-
cularization.5
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POSTERIOR LEAFLETANGLE
IN CHRONIC ISCHEMIC
MITRAL REGURGITATION
To the Editor:
I have read with great interest the
article by Fino and colleagues.1 Their
conclusions are very interesting.of Thoracic and Cardiovascular SurgerHowever, it would seem that the
success rate achieved with the
technique described originally by
Bolling and colleagues2 is unaccep-
table and the complication rate is
unacceptably high. Restrictive mitral
annuloplasty inserting a small ring,
often 26 mm or 28 mm, is based on
the principle of anterior advancement
of the posterior mitral annulus. So,
the tethered posterior leaflet (PL)
meets the anterior leaflet in a more
anterior displaced closure line.
Consequently, the effective mitral
valve area is reduced. Complete
prosthetic annuloplasty rings to treat
chronic ischemic mitral regurgitation
are an absolute must because there
is an anteroposterior annular enlarge-
ment3 in addition to the asymmetric
PL tethering.4 It is therefore clear
that, in restrictive mitral annulo-
plasty, the higher the PL angle, the
greater the need for mitral valve
closure line anterior displacement,
and more likely the possibility of
over reduction of the mitral valve
area. We have addressed this issue
in the study by Magne and col-
leagues.5 Restrictive mitral annulo-
plasty in chronic ischemic mitral
regurgitation is most likely to fail
in patients with a PL angle
greater than 45 degrees by
echocardiographic study. The best
predictor of postoperative persistence
of mitral regurgitation was a PL
angle greater than 45 degrees. Since
2011, we have selected exclusively
patients with a PL angle less than
45 degrees for restrictive mitral valve
annuloplasty in chronic ischemic
mitral regurgitation. This approach
has drastically reduced the need to
use very small rings. We had no
need to use 26-mm rings. Usually,
28-mm or 30-mm complete rings
achieve good mitral coaptation while
solving the problem of over reduc-
tion. This fact may be due to a
decreased need for anterior displace-
ment of the mitral valve closure line
when the PL angle is less than 45
degrees.y c Volume 147, Number 5 1717
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We greatly appreciated the
comments of Dr Garcia-Villareal
regarding our recent article.1 On the
basis of a previous study,2 we aimed
to analyze mitral valve hemodynamic
performance, both at rest and during
exercise, of patients with functional
mitral regurgitation (MR) who
received either restrictive annulo-
plasty or mitral valve replacement.
We agree with Dr Garcia-Villareal
that implanting the smallest ring size
(24-26 mm) would be more likely
to lead to abnormal postoperative
transmitral gradients, particularly if
the cardiac output is normal or
increased. However, in our surgical
series, only 6 patients (17%) received
a 26-mm ring, whereas 83% of our
population received a ring of 28 mm
or greater. Despite this surgical policy,1718 The Journal of Thoracic andpatients with annuloplasty showed no
exercise-induced changes in indexed
effective orifice area. In contrast, pa-
tients with mitral valve replacement
had better exercise mitral valve
hemodynamic performance andmitral
opening reserve. Thus, our results
suggest that even in patients with
relatively high implanted ring size,
exercise functional mitral stenosis,
resulting in increased systolic pulmo-
nary arterial pressure, may occur.
Our findings suggest that sparing
mitral valve replacement may be
considered as an alternative valid
surgical option, even with the obvious
limitations.
As underlined by Dr Villareal,
‘‘complete prosthetic annuloplasty
rings to treat chronic ischemic mitral
regurgitation are an absolute must as
there is an antero-posterior annular
enlargement in addition to the
asymmetric PL tethering.’’
In this context, the outcome after
mitral valve annuloplasty can largely
be predicted by a posterior high
leaflet angle (>45), regardless of the
tethering pattern.3
Any strategy aiming to avoid the
risk of persistent or recurrent MR
after surgery should be promoted and
performing a sparing mitral valve
replacement in those with high
posterior leaflet angle could be very
beneficial by reducing the need for
smaller ring size in some cases.
However, anterior leaflet restriction
should not be overlooked in under-
standing and repairing mitral valve
tethering.3
The reasonable option introduced
by Dr Villarreal, selecting rings
between 28 and 30 mm, requires
validation. Nevertheless, our data
suggest that even with a ring 28 mm
or greater, functional mitral stenosis
and limited exercise hemodynamic
performance may be frequent. This
shows the real difficulty faced by sur-
geons when selecting ring size for
mitral valve repair in patients with
functional MR; that is, to concomi-
tantly avoid persistence/recurrence ofCardiovascular Surgery c May 2014MR and risk of postoperative func-
tional mitral stenosis. Current data
from the literature seem to suggest
that whatever gains are obtained in
the reduction of recurrent MR risk by
even more restrictive annuloplasties,
they are likely to be lost by the intro-
duction of functionalmitral stenosis.1,4
Hence, despite the rule to promote
not ‘‘very aggressive undersizing,’’
restrictive mitral annuloplasty only
addresses annular dilatation with a
minimal impact on the subvalvular
tethering.
Awaiting new insights, the ideal
approach in well-selected patients
would be to consider sparing
mitral valve replacement5 or a ring
with adjunctive surgical procedures
targeting the subvalvular tethering.
Carlo Fino, MDa
Attilio Iacovoni, MDa
Julien Magne, PhDb
aCardiovascular and Transplant
Department
Ospedale ‘‘Papa Giovanni XXIII’’
Bergamo, Italy
bCHU Dupuytren
Limoges, FranceReferences
1. Fino C, Iacovoni A, Ferrero P, Senni M, Merlo M,
Cugola D, et al. Restrictive mitral valve
annuloplasty versus mitral valve replacement
for functional ischemic mitral regurgitation.
An exercise echocardiographic study. J Thorac
Cardiovasc Surg. November 4, 2013 [Epub ahead
of print].
2. Magne J, Senechal M, Mathieu P, Dumesnil JG,
Dagenais F, Pibarot P. Restrictive annuloplasty
for ischemic mitral regurgitation may induce
functional mitral stenosis. J Am Coll Cardiol.
2008;51:1692-701.
3. Magne J, Pibarot P, Dagenais F, Hachicha Z,
Dumesnil JG, Senechal M. Preoperative
posterior leaflet angle accurately predicts outcome
after restrictive mitral valve annuloplasty for
ischemic mitral regurgitation. Circulation. 2007;
115:782-91.
4. Marwick T. Restrictive annuloplasty for ischemic
mitral regurgitation: too little or too much?
J Am Coll Cardiol. 2008;51:1702-3.
5. Acker MA, Parides MK, Perrault LP,
Moskowitz AJ, Gelijins AC, Voisine P. Mitral-valve
repair versus replacement for severe ischemicmitral
regurgitation. N Engl J Med. 2014;370:23-32.
http://dx.doi.org/10.1016/
j.jtcvs.2014.01.025
